undamentalytics Newsletter

Kravis Henry R and related entities: insider trades

Officer, 10% owner at 11 companies we cover. No open-market purchases and 17 sales not made under a pre-set plan, reported from March 17, 2011 to June 5, 2026. Trades reported separately by several related funds or companies are counted once, under this name.

What happened after Kravis Henry R and related entities’s sales?

After their sales, the shares moved +11.2% against the index over 12 months on average (a negative figure means selling was the right call); 50% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Kravis Henry R and related entities: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 17 +5.4% +3.7% 35% 11 0.74 0.48 No reliable evidence
Sales, 12 months after the report 16 +11.2% −1.3% 50% 10 1.15 0.28 No reliable evidence
Sales, 12 months after the trade 16 +10.8% −3.9% 56% 10 1.12 0.29 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
HCA Healthcare HCA —02March 17, 2011February 20, 2013
Dollar General DG —02December 14, 2011October 5, 2012
National Vision Holdings, Inc. EYE —02March 21, 2018August 1, 2018
KKR & Co. KKR Co-Executive Chairman02November 5, 2021June 2, 2025
Applovin Corp APP —02August 16, 2023November 25, 2024
Brightspring Health Services, Inc. BTSG —02October 22, 2025June 5, 2026
Ingersoll Rand IR —01November 22, 2017November 22, 2017
Brightview Holdings, Inc. BV —01June 17, 2020June 17, 2020
Academy Sports & Outdoors, Inc. ASO —01February 3, 2021February 3, 2021
KKR Real Estate Finance Trust Inc. KREF —01February 11, 2021February 11, 2021
Bridgebio Pharma, Inc. BBIO —01May 14, 2025May 14, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 5, 2026June 5, 2026 BTSG Sale $857,448,115 +1.8%not yetnot yet
October 22, 2025October 22, 2025 BTSG Sale $424,361,100 +16.2%+60.6%+67.5%
June 2, 2025June 2, 2025 KKR Sale $153,755,831 +3.7%−48.7%−53.9%
May 14, 2025May 12, 2025 BBIO Sale $205,200,000 +42.8%+67.1%+63.5%
November 25, 2024November 21, 2024 APP Sale $1,634,861,106 +4.8%+74.5%+59.6%
August 16, 2023August 14, 2023 APP Sale $370,000,000 +3.5%+96.8%+89.9%
November 5, 2021November 3, 2021 KKR Sale $383,874,404 −12.2%−15.3%−22.3%
February 11, 2021February 9, 2021 KREF Sale $4,007,604 +4.7%+9.2%+11.0%
February 3, 2021February 1, 2021 ASO Sale $247,184,651 +33.3%+39.0%+54.8%
June 17, 2020June 15, 2020 BV Sale $103,152,880 −0.8%+3.5%−0.8%
August 1, 2018July 30, 2018 EYE Sale $438,165,801 +5.8%−31.1%−29.6%
March 21, 2018March 19, 2018 EYE Sale $305,146,354 +15.0%−17.5%−17.3%
November 22, 2017November 20, 2017 IR Sale $667,380,758 −1.0%−24.5%−24.8%
February 20, 2013February 15, 2013 HCA Sale $856,746,018 −6.6%+15.0%+13.8%
October 5, 2012October 3, 2012 DG Sale $940,144,094 −16.7%−6.0%−7.1%
December 14, 2011December 12, 2011 DG Sale $548,146,013 −7.1%−13.5%−8.5%
March 17, 2011March 15, 2011 HCA Sale $456,618,937 +4.7%−30.4%−22.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Kravis Henry R and related entities traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.